Aditxt, Inc. Retained Earnings
Aditxt, Inc. (ADTX) had Retained Earnings of -$225.76 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-20
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$225.76M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$209.81M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$205.11M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$181.06M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-03-31 | -$225.76M 10-Q · filed 2026-05-20 |
| 2025-12-31 | -$209.81M 10-Q · filed 2026-05-20 |
| 2025-09-30 | -$205.11M 10-Q · filed 2025-11-18 |
| 2025-06-30 | -$181.06M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$173.80M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$168.09M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$162.87M 10-Q · filed 2024-11-18 |
| 2024-06-30 | -$150.02M 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$142.47M 10-Q · filed 2024-05-20 |
| 2023-12-31 | -$127.74M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$116.62M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$106.71M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$101.03M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$95.04M 10-K · filed 2024-04-16 |
| 2022-09-30 | -$86.83M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$79.26M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$73.41M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$67.35M 10-K · filed 2023-04-17 |
| 2021-09-30 | -$43.30M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$33.44M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$27.26M 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$20.88M 10-K · filed 2022-03-31 |
| 2020-09-30 | -$16.20M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$13.45M 10-Q · filed 2020-08-13 |
| 2019-12-31 | -$11.73M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |